ReviR Therapeutics

ReviR Therapeutics (ReviR Therapeutics), is an innovative drug discovery company driven by artificial intelligence algorithms and gene technology, focusing on RNA spatial structure computation. It has built the voyageR™ AI platform to develop small molecule drugs targeting RNA, addressing unmet clinical needs in oncology, infectious diseases, and rare diseases. ReviR was founded in 2021 in Silicon Valley and Shenzhen. The core team comes from multinational pharmaceutical companies and world-renowned medical research centers, with nearly 20 years of experience in drug discovery, computational chemistry, and computational biology at Genentech, Gilead, AbbVie, 23andMe, and Invitae.